Cerebrolysin 60mg Neuropeptide Complex | Cognitive & Neurorestorative Research Peptide
Cerebrolysin 60mg Neuropeptide Complex | Cognitive & Neurorestorative Research Peptide
Cerebrolysin 60mg Neuropeptide Complex | Cognitive & Neurorestorative Research Peptide
Overview Cerebrolysin is a unique neuropeptide preparation derived from purified porcine brain tissue, comprised of a defined mixture of low molecular weight biologically active peptides and free amino acids. Unlike single-sequence research peptides, Cerebrolysin represents a multi-component neurotrophic complex — engineered to mimic the action of endogenous neurotrophic factors. The 60mg presentation is developed for advanced research into neuroprotection, cognitive function, and neuroregenerative biology.
Mechanism of Interest Cerebrolysin is one of the most extensively investigated neuropeptide preparations in modern neuroscience research, with a body of literature spanning decades. Research has explored its role as a neurotrophic mimetic — engaging signalling pathways associated with brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and ciliary neurotrophic factor (CNTF). It is widely studied for its influence on neuronal survival, synaptic plasticity, neurogenesis, oxidative stress modulation, and protection against excitotoxicity.
Product Specifications
- Product Name: Cerebrolysin 60mg
- Catalogue Reference: CERE60-024
- Class: Porcine-derived neuropeptide complex
- Composition: Low molecular weight neuropeptides (≤10 kDa) and free amino acids
- Purity: Research-grade preparation, batch verified
- Presentation: Lyophilised solid (research formulation)
- Storage: 2–8°C (refer to batch documentation for optimal storage)
Research Applications Cerebrolysin is utilised across neuroscience, cognitive research, and neurorestorative biology — particularly in studies investigating ischaemic and traumatic brain injury models, neurodegenerative pathways (including Alzheimer's and vascular dementia models), stroke recovery research, cognitive performance, neuroplasticity, and developmental neurobiology. Its multi-peptide architecture makes it a uniquely positioned research tool where complex neurotrophic signalling is the focus of investigation.
Distinct Research Profile Unlike monomolecular peptides, Cerebrolysin's value in research lies in its synergistic multi-component action — making it a reference compound in the field of neurotrophic and neurorestorative peptide science. It is frequently studied as a comparative or adjunct preparation alongside isolated neurotrophic peptides and small-molecule neuroprotective agents.
Quality & Handling Supplied under controlled conditions to preserve the integrity of the peptide complex. Reconstitution with appropriate sterile diluent is required prior to use in any research model — refer to batch-specific documentation for full reconstitution and handling guidance. Every batch is subjected to rigorous quality control to ensure compositional consistency, stability, and reproducibility.
Compliance Statement All Asclepius research products, including Cerebrolysin, are supplied strictly for laboratory research purposes. They are not intended for human consumption, diagnosis, treatment, or therapeutic use. Enquiries relating to human application cannot be supported.
Order with Confidence Asclepius research compounds are sourced, tested, and dispatched to a clinical standard — built for researchers and practitioners who refuse to compromise on integrity, purity, or precision.
For technical specifications, certificates of analysis, or research support, our team is available to assist.